Effects of Ankle Mobilization on Body Structure, Function, Activities and Participation of Children With Cerebral Palsy
The Effects of Ankle Mulligan Mobilization on Range of Motion, Balance, Functional Performance and Quality of Life of Children With Diplegic Spastic Cerebral Palsy
1 other identifier
interventional
64
1 country
1
Brief Summary
Cerebral palsy is the most common motor disability of childhood (Suvanand et al 1997). By definition CP is a static encephalopathy, but the musculoskeletal pathology is a major concern . Chronic neurologic impairment affects the development of bones and muscles. In spastic hemiplegia, the affected side demonstrates muscle atrophy and limb shortening, compared to the unaffected side. Thus, CP is a neuromusculoskeletal disorder . Musculoskeletal conditions of people with CP can develop or worsen across the lifespan as a consequence of the primary neuromotor impairments which will affect their physical activity and participation. In fact these complications can lead to lose the ability of walking in ambulatory children up to 30% . (Peterson 2015) Physical inactivity among regularly growing paediatric community has become a general health load. Neurological interventions are well documented, However, there is a gap of information and evidence documenting the orthopaedic intervention effect on orthopaedic secondary complications in CP. Even though the neurological pathology isn't progressive , the orthopaedic complication itself is progressive and affect the ability of the CP children to progress, and in so many cases they lose their functional achievements when their functional status can't meet their growth requirements any more, due to the neurological dysfunction and progressive secondary complications, that makes walking less efficient , less effective, and increased fatigue levels in gait. (Tosi et al. 2009). Little is known about the practice of Brian Mulligan's mobilization with movement (MWM) in CP patients in early ages, for the secondary complication of the ankle hypomobility and ROM. This study will be conducted to discover the immediate effect of MWM on the ankle to improve the range and mobility of ankle as a musculoskeletal (dysfunction) for the function of gait.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 30, 2022
CompletedFirst Submitted
Initial submission to the registry
August 4, 2022
CompletedFirst Posted
Study publicly available on registry
August 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 22, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 10, 2023
CompletedJanuary 12, 2023
December 1, 2022
5 months
August 4, 2022
January 11, 2023
Conditions
Outcome Measures
Primary Outcomes (5)
Change of Ankle Range of Motion
ROM of Ankle Dorsiflexion passively and actively will be done using goniometer to assess any changes.
Baseline and post 4 weeks assessment
Change in the Six minutes walking test: The six-minute walk test (6MWT) measures the distance an individual is able to walk over a total of six minutes on a hard, flat surface
For measuring the changes in walking activities.The six-minute walk test (6MWT) measures the distance an individual is able to walk over a total of six minutes on a hard, flat surface
Baseline and post 4 weeks assessment
Change inTime up and go (TUG) test: The TUG test is a reliable and responsive measure of balance and mobility for children with CP
For assessing the change in Balance and mobility
Baseline and post 4 weeks assessment
Change in the Pediatric Quality of Life: it is measured by measure by CP-specific questionnaire. We will use The Arabic-CP-QOL-questionnaire
To assess the change in the quality of life and happiness of the children
Baseline and post 4 weeks assessment
Change in the Gross Motor Function Measure (GMFM) scale which is designed to measure changes in gross motor function over time or with intervention in children with cerebral palsy.
To assess the changes in the Functional performance in thegross motor function of Cerebral Palsy children
Baseline and post 4 weeks assessment
Study Arms (2)
Intervention group
EXPERIMENTAL5 sets of functional activities each will be repeated for 3 times , while the therapist is performing mulligan mobilization techniques Sit to stand Squat Stand to sit Stairs stepping Bridging
Control group
EXPERIMENTAL5 sets of functional activities each will be repeated for 3 times: Sit to stand Squat Stand to sit Stairs stepping Bridging
Interventions
5 sets of functional activities each will be repeated for 3 times , while the therapist is performing mulligan mobilization techniques Sit to stand Squat Stand to sit Stairs stepping Bridging
Eligibility Criteria
You may qualify if:
- Spastic Diplegic CP
- healthy bones appropriate for mobilisation
- ages between 4-14
- GMFCS I, II
- Ashworth scale 2-3 (For Gastrocnemius Muscle)
- Good cognitive ability to understand the orders in the tests
- CP children who continued to take regular physiotherapy sessions
You may not qualify if:
- Recent correcting orthopaedic surgeries until 6 months before recruitment
- Children received or intending to receive Botox within an interval of 3 months
- Children who have full Ankle dorsal flexion.
- fixed contracture
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Palestine Ahliya university
Bethlehem, p158, Palestinian Territories
Related Publications (1)
Ragheb Abushameh RS, Topcu ZG, Tunal AN, Amro A, Arab AA. The effects of ankle mulligan mobilisation in children with cerebral palsy: A randomized single blind control study. J Pak Med Assoc. 2024 Jul;74(7):1219-1223. doi: 10.47391/JPMA.10328.
PMID: 39028043DERIVED
Study Officials
- STUDY DIRECTOR
Zehra G. Topco, PhD
Eastern Medeterranean University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 4, 2022
First Posted
August 15, 2022
Study Start
July 30, 2022
Primary Completion
December 22, 2022
Study Completion
January 10, 2023
Last Updated
January 12, 2023
Record last verified: 2022-12
Data Sharing
- IPD Sharing
- Will not share